Fig. 4From: Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinomaMetastatic heterogeneity. The minor clone in the primary lesion turns into a major clone in metastatic lesions. In this way, biomarkers of primary lesions could not be used to accurately estimate the state of metastatic lesionsBack to article page